Clinical Trial Details
— Status: Completed
Administrative data
| NCT number |
NCT03679403 |
| Other study ID # |
201701033RIND |
| Secondary ID |
|
| Status |
Completed |
| Phase |
|
| First received |
|
| Last updated |
|
| Start date |
August 1, 2017 |
| Est. completion date |
July 31, 2020 |
Study information
| Verified date |
September 2021 |
| Source |
National Taiwan University Hospital |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Observational
|
Clinical Trial Summary
Attention deficit/hyperactivity disorder (ADHD) is a common (3-10%), early-onset, clinically
and genetically heterogeneous neuropsychiatric disorder with lifelong neuropsychological
deficits. Despite many imaging studies on ADHD across countries, only few longitudinal
studies investigated the developmental changes of structural and functional brain
connectivity and some imaging studies using unaffected sibling design in western countries.
There is no published data regarding developmental changes in brain functions assessed by
neuropsychology/physiology/image in Asia and Taiwan as well. The ultimate goals of this
3-year project are to identify which neuropsychological, functional and structural
connectivity, and neurophysiological variables can be effective endophenotypes (biomarkers)
for ADHD based on this follow-up unaffected sibling study design. Due to the limitation of
diffusion tensor image (DTI), original analysis of diffusion spectrum image (DSI), and
single-echo resting-state functional MRI (SE rsfMRI), the investigators will adopt Mean
Apparent Propagator (MAP)-MRI, tract-based autonomic analysis (TBAA) and multi-echo (ME)
rsfMRI in this project. With the accomplishment of the following study goals, this study will
be the first longitudinal follow-up neuroimaging/physiological endophenotypes study on ADHD
using advanced imaging techniques and comprehensive clinical and neurocognitive data.
Description:
Primary Aim:
1. To examine the developmental changes and stability of neuropsychological functions (NFs,
assessed by CPT and CANTAB) and structural (morphometric, cortical thickness,
gyrification, fiber tract integrity) and functional connectivity (assessed by SE rsfMRI,
counting-Stroop fMRI) from childhood to late adolescence and young adulthood;
Secondary Aims:
2. To validate a wide range of neuropsychological functions (assessed by CPT, CANTAB, CNB),
structural and functional connectivity in the frontostriatal (FS), frontoparietal (FP)
and other circuitries, and neurophysiological functions (assessed by event-related
potential [ERP]: MMN, Gamma ARRS) as effective imaging endophenotypes by demonstrating
the intermediate position of unaffected siblings between ADHD probands, and age-, sex-,
and handedness-matched neurotypicals at Time 1 and Follow-up;
3. To identify the Time 1 predictors (behavioral symptoms, NFs, and imaging data) for
Follow-up neuroimaging data (Morphometric, DSI, rfMRI, task-fMRI, MMN, Gamma ARRS); and
4. To correlate all kinds of neurocognitive data and clinical symptoms profiles stratifying
by the presence of ADHD, proband-unaffected sibling dyads, and two time points.
Hypothesis The investigators anticipated despite increasing thinning of cortical thickness,
microstructural integrity of several targets fiber tracts, and brain activity of target brain
regions and improving neuropsychiatric performance from childhood to late adolescence/young
adulthood in neurotypicals and probably in ADHD with lower developmental changes slope in
ADHD. These changes of unaffected siblings are in the intermediate position between the ADHD
probands and neurotypicals. For the endophenotype part, the investigators anticipate that
ADHD probands may have a higher level of altered microstructural integrity and decreased
brain activity of the FS, FP, other hypothesized fiber tracts/brain networks, deficits in MMN
and Gamma, and impaired a wide-ranging NFs than neurotypicals. These differences in the
unaffected siblings would be in the intermediate position between ADHD probands and
neurotypicals.